| Literature DB >> 25976763 |
Chun-Yu Lin1, Tun-Chieh Chen1, Chia-Yen Dai2, Ming-Lung Yu2, Po-Liang Lu1, Jeng-Hsien Yen3, Yen-Hsu Chen1.
Abstract
OBJECTIVES: After Typhoon Morakot struck Taiwan in 2009, thousands of Taiwanese citizens were displaced to shelters for several weeks. Others were placed in urban communities where they had family members. This study aimed to investigate serological status in both groups and identify risk factors associated with seroconversion of infectious diseases.Entities:
Keywords: EPIDEMIOLOGY; INFECTIOUS DISEASES
Mesh:
Substances:
Year: 2015 PMID: 25976763 PMCID: PMC4442151 DOI: 10.1136/bmjopen-2014-007008
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Serological test kits used in the present study
| Disease | Products | Manufacturer | City | Country |
|---|---|---|---|---|
| Measles | Measles virus IgG–ELISA | NovaLisa | Dietzenbach | Germany |
| Mumps | Mumps virus IgG–ELISA | NovaLisa | Dietzenbach | Germany |
| Rubella | Rubella virus IgG–ELISA | NovaLisa | Dietzenbach | Germany |
| Amoebiasis (IHA) | Cellognost–Amoebiasis | Behring Diagnostics | Marburg | Germany |
| Leptospirosis | CTK Biotech, Inc | San Diego, CA | USA | |
| HSV-1 | Anti-HSV-1 ELISA (IgG) | Euroimmun | Lübeck | Germany |
| HSV-2 | Anti-HSV-2 ELISA (IgG) | Euroimmun | Lübeck | Germany |
| VDRL of syphilis | Syphilis RPR Test | Human | Wiesbaden | Germany |
HSV, herpes simplex virus; RPR, rapid plasma reagin; VDRL, Venereal Disease Research Laboratory.
Participants’ demographics, medical history and laboratory data by group (N=288)
| Variables | Total | Shelter group | Community group | p Value |
|---|---|---|---|---|
| Demographics | ||||
| Gender, male (%) | 96 (33.3) | 37 (32.5) | 59 (33.9) | 0.798 |
| Age ≥65 years, n (%) | 94 (32.6) | 30 (26.3) | 64 (36.8) | 0.064 |
| BMI | 28.20±4.92 | 28.60±4.67 | 27.94±5.08 | 0.268 |
| Ratio of waist and hip | 0.90±0.07 | 0.89±0.07 | 0.90±0.07 | 0.266 |
| Education | 0.913 | |||
| Junior high school or lower | 159 (55.2%) | 64 (56.1%) | 95 (54.6%) | |
| High school and college | 54 (18.8%) | 20 (17.5%) | 34 (19.5%) | |
| Without formal education and unknown | 75 (26.0%) | 30 (26.3%) | 45 (25.9%) | |
| Single¶, n (%) | 121 (42.0) | 46 (40.4) | 75 (43.1) | 0.643 |
| Family with major trauma | 10 (3.5) | 6 (5.3) | 4 (2.3) | 0.201 |
| Medical history | ||||
| Hypertension | 127 (46.2) | 53 (47.3) | 74 (45.4) | 0.753 |
| Diabetes mellitus | 45 (16.4) | 20 (17.9) | 25 (15.3) | 0.579 |
| Hyperlipidaemia | 177 (61.5) | 20 (17.9) | 111 (63.8) | 0.315 |
| Hyperuricaemia | 91 (31.6) | 33 (28.9) | 58 (33.3) | 0.434 |
| Ischaemic heart disease | 10 (3.6) | 5 (4.5) | 5 (3.1) | 0.543 |
| Gouty arthritis | 35 (12.7) | 19 (17.0) | 16 (9.8) | 0.081 |
| Cerebrovascular disease | 6 (2.2) | 1 (0.9) | 5 (3.1) | 0.406 |
| Laboratory data | ||||
| After typhoon (first round) | ||||
| SERUM GPT >40 IU/L | 49 (17.0) | 23 (20.2) | 26 (14.9) | 0.248 |
| Creatinine >1.5 mg/dL | 22 (7.6) | 8 (7.0) | 14 (8.0) | 0.748 |
| Serum albumin, mg/dL | 4.40 (4.30, 4.60) | 4.40 (4.30, 4.60) | 4.40 (4.20, 4.60) | 0.227 |
| Total cholesterol, mg/dL | 203.98±46.34 | 197.85±37.00 | 208.00±51.26 | 0.084 |
| Triglyceride, mg/dL | 150 (92, 233.25) | 142 (89.75, 219.25) | 155.50 (92.00, 242.75) | 0.111 |
| Follow-up (second round) | ||||
| SERUM GPT>40 IU/L | 56 (19.4) | 33 (28.9)‡ | 23 (13.2) | 0.001* |
| Creatinine >1.5 mg/dL | 20 (6.9) | 6 (5.3) | 14 (8.0) | 0.364 |
| Serum albumin, mg/dL | 4.30 (4.20, 4.50)† | 4.30 (4.20, 4.50)‡ | 4.30 (4.18, 4.50)§ | 0.447 |
| Total cholesterol, mg/dL | 194.99±41.09† | 188.65±38.33‡ | 199.15±42.40§ | 0.034* |
| Triglyceride, mg/dL | 150 (102, 257.50)† | 142.50 (98.25, 208.75) | 156.50 (102, 275)§ | 0.240 |
Data are summarised as n (%) for categorical variables, mean±SD for continuous variables and median (IQR: Q1, Q3) for continuous variables without normal distribution.
Differences between shelter and community groups in categorical data were compared using Pearson χ2 test or Fisher's exact test if there were any cases numbering less than five; for continuous data, differences between shelter group and community group were compared using two-sample t test, and Mann-Whitney U test, in data without normal distribution.
*p<0.05, indicates significant differences between shelter and community groups.
†‡§P<0.05, indicates significant differences when comparing data after typhoon in †total, ‡shelter group and §community group, separately.
¶Including divorced or unmarried participants, or widows or widowers.
BMI, body mass index.
Positive results after the typhoon and during follow-up (N=288)
| Variables | Total (n=288) | Shelter group (n=114) | Community group (n=174) | p Value |
|---|---|---|---|---|
| Vaccine-preventable diseases | ||||
| Measles | 261 (90.6) | 102 (89.5) | 159 (91.4) | 0.587 |
| Mumps | 214 (74.3) | 93 (81.6) | 121 (69.5) | 0.022* |
| Rubella | 230 (79.9) | 91 (79.9) | 139 (79.9) | 0.990 |
| Water-borne diseases | ||||
| Amoebiasis test <1:16 | 89 (30.9) | 41 (36.0) | 48 (27.6) | 0.132 |
| Leptospirosis | 2 (2 (0.7) | 0 (0) | 2 (1.1) | NA |
| Miscellaneous | ||||
| HSV-1 | 245 (85.1) | 96 (84.2) | 149 (85.6) | 0.741 |
| HSV-2 | 101 (35.1) | 31 (27.2) | 70 (40.2) | 0.023* |
| VDRL for syphilis | 2 (0.7) | 1 (0.9) | 1 (0.6) | 1.000 |
| Vaccine-preventable diseases | ||||
| Measles seroconversion (n=27) | 1 (3.7) | 1 (8.3) | 0 (0) | NA |
| Mumps seroconversion (n=74) | 3 (4.1) | 2 (9.5) | 1 (1.9) | 0.192 |
| Rubella seroconversion (n=58) | 10 (17.2) | 5 (21.7) | 5 (14.3) | 0.496 |
| Water-borne diseases | ||||
| Amoebiasis test <1:16 | 21 (23.6) | 9 (22.0) | 12 (25.0) | 0.806 |
| Leptospirosis (n=286) | 0 (0) | 0 (0) | 0 (0) | NA |
| Miscellaneous | ||||
| HSV-1 (n=43) | 6 (13.9) | 3 (16.7) | 3 (12) | 0.683 |
| HSV-2 (n=187) | 3 (1.6) | 2 (2.4) | 1 (1.0) | 0.585 |
| VDRL for syphilis (n=286) | 0 (0) | 0 (0) | 0 (0) | NA |
| With amoebiasis (IHA) seroconversion | 0.001* | |||
| Yes | 128 (44.4) | 64 (56.1) | 64 (36.8) | |
| No | 160 (55.6) | 50 (43.9) | 110 (63.2) | |
Data are presented as n (%) by accommodations (shelter vs community), and compared using Pearson χ2 test or Fisher's exact test if any cells number less than five.
*p<0.05 indicates significant difference between shelter and community groups.
†Second round testing was carried out for those participants who had negative results after the first round of testing.
HSV, herpes simplex virus; VDRL, Venereal Disease Research Laboratory.
Associations between accommodations, participants’ demographics, medical history, laboratory data and seroconversion (N=288)
| Variables | Seroconversion | Without seroconversion | p Value |
|---|---|---|---|
| Accommodations | 0.001* | ||
| Community | 64 (36.8) | 110 (63.2) | |
| Shelter | 64 (56.1) | 50 (43.9) | |
| Demographics | |||
| Gender | 0.933 | ||
| Males | 43 (44.8) | 53 (55.2) | |
| Females | 85 (44.3) | 107 (55.7) | |
| Age ≥65 years | 0.955 | ||
| No | 86 (44.3) | 108 (55.7) | |
| Yes | 42 (44.7) | 52 (55.3) | |
| Age, yrs | 59.02±12.33 | 57.94±13.05 | 0.475 |
| BMI, kg/m2 | 28.29±4.81 | 28.13±5.02 | 0.788 |
| Ratio of waist and hip | 0.90±0.07 | 0.89±0.07 | 0.491 |
| Education | 0.919 | ||
| Junior high school or lower | 69 (43.4) | 90 (56.6) | |
| High school and college | 25 (46.3) | 29 (53.7) | |
| Without formal education and unknown | 34 (45.3) | 41 (54.7) | |
| Single†, n (%) | 0.364 | ||
| No | 78 (46.7) | 89 (53.3) | |
| Yes | 50 (41.3) | 71 (58.7) | |
| Family with major trauma | 0.348 | ||
| No | 122 (43.9) | 156 (56.1) | |
| Yes | 6 (60.0) | 4 (40.0) | |
| Medical history | |||
| Hypertension | 66 (52.0) | 61 (48.0) | 0.044* |
| Diabetes mellitus | 24 (53.3) | 21 (46.7) | 0.246 |
| Hyperlipidaemia | 70 (39.5) | 107 (60.5) | 0.035* |
| Hyperuricaemia | 44 (48.4) | 47 (51.6) | 0.436 |
| Ischaemic heart disease | 3 (30.0) | 7 (70.0) | 0.246 |
| Gouty arthritis | 16 (45.7) | 19 (54.3) | 0.974 |
| Cerebrovascular disease | 3 (50.0) | 3 (50.0) | 1.000 |
| Laboratory data | |||
| Pretest | |||
| Serum GPT >40 IU/L | 23 (46.9) | 26 (53.1) | 0.700 |
| Creatinine >1.5 mg/dL | 7 (31.8) | 15 (68.2) | 0.215 |
| Serum albumin, mg/dL | 4.40 (4.30, 4.60) | 4.40 (4.30, 4.60) | 0.302 |
| Total cholesterol, mg/dL | 200.16±36.32 | 207.04±52.93 | 0.194 |
| Triglyceride, mg/dL | 148.50 (84.00, 202.50) | 160.50 (95.30, 261.00) | 0.167 |
| Follow-up | |||
| Serum GPT >40 IU/L | 29 (51.8) | 27 (48.2) | 0.218 |
| Creatinine >1.5 mg/dL | 7 (35.0) | 13 (65.0) | 0.378 |
| Serum albumin, mg/dL | 4.30 (4.10, 4.40) | 4.30 (4.20, 4.50) | 0.087 |
| Total cholesterol, mg/dL | 191.74±39.90 | 197.59±41.96 | 0.230 |
| Triglyceride, mg/dL | 193.00 (162.00, 214.75) | 156.50 (106.00, 261.00) | 0.248 |
Data are summarised as n (%) for categorical variables, mean±SD for continuous variables, and median (IQR: Q1, Q3) for continuous variables without normal distribution.
Differences between participants with and without seroconversion in categorical data were compared using Pearson χ2 test or Fisher's exact test if there were any cells numbering less than five; for continuous data, differences between participants with and without seroconversion were compared using two-sample t test and Mann-Whitney U test in data without normal distribution.
*p<0.05, indicates significant differences between participants with and without seroconversion.
†Including divorced or unmarried participants, or widows or widowers.
BMI, body mass index.
Figure 1Amoebiasis indirect haemagglutination (IHA) seroconversion rate in groups with different lengths of stay in the shelters.
Univariate and multivariate logistic regression models analysis of seroconversion (N=288)
| Univariate | Multivariate | |||
|---|---|---|---|---|
| Variables† | OR (95% CI) | p Value | OR (95% CI) | p Value |
| Shelter admission | ||||
| Shelter versus community | 2.200 (1.359 to 3.561) | 0.001* | 2.055 (1.251 to 3.374) | 0.004* |
| Medical history | ||||
| Hypertension | 1.632 (1.011 to 2.635) | 0.045* | 1.576 (0.964 to 2.575) | 0.070 |
| Hyperlipidaemia | 0.598 (0.370 to 0.965) | 0.035* | 0.642 (0.389 to 1.060) | 0.083 |
Results are presented as OR and corresponding 95% CIs of OR (95% CI) and p values.
*Indicates significance (p<0.05).
†Variables with significant association with seroconversion were selected into models.